Matthew Richard Moore - SVP and Chief Business Officer at Arcutis Biotherapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
SVP and Chief Business Officer
Stock Symbol
ARQT on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Matthew Richard Moore since 12/5/2024

Holdings reported by Matthew Richard Moore for Arcutis Biotherapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 146K $1.27M $8.74 May 2, 2024 Direct
Stock Option (Right to Buy) 0 Feb 13, 2024 Direct Common Stock

Transactions reported by Matthew Richard Moore for Arcutis Biotherapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.